Biosimilars · Insulin · GLP-1 · Anticoagulants

Advancing Biosimilars.
Transforming Lives.

Making life-changing biologic therapies accessible and affordable for patients worldwide.

0 Sq Ft GMP Facility
at MEPZ-SEZ Chennai
0 Countries Targeted
by 2028
WHO-GMP Certified · DCGI Approved
Schedule M Compliant
Regenix Biosciences manufacturing facility — MEPZ-SEZ, Tambaram, Chennai
Our 30,000 sq ft GMP facility — MEPZ-SEZ, Tambaram, Chennai.
Certified · Approved · Trusted
WHO-GMP Certified
DCGI Approved
CDSCO Registered
ISO 9001:2015
Schedule M Compliant
Why Regenix

Built for the most demanding markets in biologic therapy.

From formulation through regulatory filing, every link in our delivery chain is engineered for the standards regulators, distributors and patients depend on.

Explore capabilities
  • End-to-end manufacturing in one facility

    Formulation, sterile fill-finish, bioequivalence and regulatory filing — all under one roof in Chennai.

  • Audit-ready quality systems

    WHO-GMP, DCGI and CDSCO approved. ISO 9001:2015 certified. Schedule M compliant.

  • Global reach by 2028

    Active exports across four regions today. 120+ markets targeted. Full CTD dossiers ready for transfer.

  • B2B partnership-ready

    Licensing, contract manufacturing, co-development and regional distribution — flexible engagement models for every value-chain role.

Featured Portfolio

Six biosimilars. One commitment to access.

View full portfolio →

Building a market? Let's build it together.

From licensing and dossier transfer to private-label fill-finish — our partnerships team responds within two business days.

Explore Partnership Models
News & Announcements

The latest from Regenix.

All news →